Related Experiment Video
Updated: Jun 27, 2026
12:04
The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
Published on: November 1, 2015
Hepatitis C virus and systemic lupus erythematosus
1Heartland Arthritis Treatment Center, St. Joseph, Missouri and the University of Mississippi Medical Center/Jackson Veterans Affairs Medical Center, Jackson, Mississippi.
Summary
Hepatitis C virus (HCV) infection can trigger autoimmune diseases like systemic lupus erythematosus (SLE). This case report shows successful treatment of autoimmune symptoms in a patient with concurrent HCV, hepatitis, glomerulonephritis, and SLE using corticosteroids and cyclophosphamide.
Area of Science:
- Hepatology
- Rheumatology
- Nephrology
- Immunology
Background:
- Hepatitis C virus (HCV) infection is linked to various autoimmune manifestations.
- Systemic lupus erythematosus (SLE) and HCV share overlapping clinical features, including autoantibodies, immune complex formation, polyarthritis, hepatitis, and glomerulonephritis.
Purpose of the Study:
- To present a case of a patient with simultaneous HCV infection and SLE.
- To discuss the management of autoimmune responses in the context of concurrent HCV and SLE.
- To highlight the importance of screening for HCV in patients with lupus-like illnesses.
Main Methods:
- Case report detailing a patient with concurrent HCV infection, hepatitis, glomerulonephritis, and SLE.
- Therapeutic intervention using corticosteroids and cyclophosphamide.
- Discussion of the clinical challenges and diagnostic considerations.
Main Results:
- Effective control of certain autoimmune responses was achieved with corticosteroids and cyclophosphamide.
- The case illustrates the complex interplay between HCV infection and SLE.
- The patient presented with overlapping symptoms of hepatitis, glomerulonephritis, and SLE.
Conclusions:
- Autoimmunity in HCV infection poses a clinical dilemma, often overlapping with SLE.
- Screening for HCV is crucial in patients with lupus-like conditions, especially those with hepatitis risk factors or elevated transaminases.
- Corticosteroids and cyclophosphamide can effectively manage autoimmune manifestations in such cases.
Related Concept Videos
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:27Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:25Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...